Test System for Trifunctional Antibodies in 3D MCTS Culture
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The aim of the present study was to assess the feasibility of a 3D tumor cell culture model, that is, multicellular tumor spheroids (MCTSs) as an adequate model for micrometastases and therefore as a pharmacological model for efficacy testing of trifunctional therapeutic antibodies. Unlike conventional monolayer cultures, spheroids allow researchers to study parameters, such as 3D cell shape, 3D cell arrangement and microenvironment, and penetration efficiency of defense cells that may largely influence the efficacy of antibody treatment in vivo. The authors established a long-term coculture of human MCTSs with peripheral blood mononuclear cells (PBMCs) to test the anticancer effect of the trifunctional, bispecific antibody catumaxomab (anti-EpCAM x anti-CD3) or similar therapeutic molecules. The test system is accessible to various analytical methods and thus allows for characterizing multiple parameters, which can help elucidate the mode of action of immunotherapeutic anticancer treatment. For example, the novel approach enables precise, reproducible volume growth analysis of MCTSs under immunotherapeutic treatments. For evaluation of changes within individual spheroids, cryosections can be stained (e.g., for proliferating or apoptotic cells as well as infiltrating PBMCs). Molecular PCR-based assays or flow cytometric analyses allow for discrimination between different cell types, particularly leukocyte subtypes. Furthermore, MCTSs can be disaggregated to form standard monolayers for cell viability or plating efficiency experiments. For these reasons, the MCTS model is a powerful tool to analyze drug efficacy with various endpoints under highly reproducible, standardized conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483 · cited 1×
“5 ng/ mL catumaxomab + PBMC (3); a positive control (4); and a negative control (5) and a marker (M) pUC19/Msp I (Roth, Karlsruhe, Germany).”
BackgroundKelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611618104 · Cited by 526
Burges, A., Wimberger, P., Kümper, C., Gorbounova, V., Sommer, H., Schmalfeldt, B., Pfisterer, J., Lichinitser, M., Makhson, A., Moiseyenko, V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2769 · Cited by 257
Lindhofer, H., Mocikat, R., Steipe, B., & Thierfelder, S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.219 · Cited by 213
Zeidler, R., Reisbach, G., Wollenberg, B., Lang, S., Chaubal, S., Schmitt, B., & Lindhofer, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1246 · Cited by 204
Research works printed but not linked: 24
- Abbott, 2003, Cell culture: biology’s new dimension., Nature, 424, 870, 10.1038/424870a · DOI · Paper page
- Kunz-Schughart, 1998, Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology., Int J Exp Pathol, 79, 1, 10.1046/j.1365-2613.1998.00051.x · DOI · Paper page
- Rodriguez-Enriquez, 2008, Energy metabolism transition in multi-cellular human tumor spheroids., J Cell Physiol, 216, 189, 10.1002/jcp.21392 · DOI · Paper page
- Griffith, 2006, Capturing complex 3D tissue physiology in vitro., Nat Rev Mol Cell Biol, 7, 211, 10.1038/nrm1858 · DOI · Paper page
- Sutherland, 1970, A multi-component radiation survival curve using an in vitro tumour model., Int J Radiat Biol Relat Stud Phys Chem Med, 18, 491, 10.1080/09553007014551401 · DOI · Paper page
- Mueller-Klieser, 2000, Tumor biology and experimental therapeutics., Crit Rev Oncol Hematol, 36, 123, 10.1016/S1040-8428(00)00082-2 · DOI · Paper page
- Mueller-Klieser, 1997, Three-dimensional cell cultures: from molecular mechanisms to clinical applications., Am J Physiol, 273, C1109, 10.1152/ajpcell.1997.273.4.C1109 · DOI · Paper page
- Gottfried, 2006, Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions., Cell Cycle, 5, 691, 10.4161/cc.5.7.2624 · DOI · Paper page
- Riechelmann, 2007, Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial., Cancer Immunol Immunother, 56, 1397, 10.1007/s00262-007-0283-6 · DOI
- Sebastian, 2007, Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study., Cancer Immunol Immunother, 56, 1637, 10.1007/s00262-007-0310-7 · DOI
- Yuhas, 1977, A simplified method for production and growth of multicellular tumor spheroids., Cancer Res, 37, 3639
- Konur, 1996, Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation., Int J Cancer, 66, 645, 10.1002/(SICI)1097-0215(19960529)66:5<645::AID-IJC11>3.0.CO;2-3 · DOI · Paper page
- Winsor, 1932, The Gompertz curve as a growth curve., Proc Natl Acad Sci USA, 18, 1, 10.1073/pnas.18.1.1 · DOI · Paper page
- Schafer, 2007, IL-6 involvement in epithelial cancers., J Clin Invest, 117, 3660, 10.1172/JCI34237 · DOI · Paper page
- Naito, 1998, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer., Cancer Res, 58, 3491
- Guo, 2007, Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma., Dis Esophagus, 20, 107, 10.1111/j.1442-2050.2007.00655.x · DOI
- Hasselblom, 2007, The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma., Br J Haematol, 137, 364, 10.1111/j.1365-2141.2007.06593.x · DOI
- Ohtani, 2007, Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer., Cancer Immunol, 7, 4
- Sato, 2005, Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer., Proc Natl Acad Sci USA, 102, 18538, 10.1073/pnas.0509182102 · DOI · Paper page
- Zhang, 2003, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer., N Engl J Med, 348, 203, 10.1056/NEJMoa020177 · DOI · Paper page
- Loughlin, 2007, Quantifying tumour-infiltrating lymphocyte subsets: a practical immunohistochemical method., J Immunol Methods, 321, 32, 10.1016/j.jim.2007.01.012 · DOI
- Del Duca, 2004, Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion., J Neurooncol, 67, 295, 10.1023/B:NEON.0000024220.07063.70 · DOI · Paper page
- Friedrich, 2007, Experimental anti-tumor therapy in 3-D: spheroids—old hat or new challenge?, Int J Radiat Biol, 83, 849, 10.1080/09553000701727531 · DOI · Paper page
- Vamvakidou, 2007, Heterogeneous breast tumoroids: an in vitro assay for investigating cellular heterogeneity and drug delivery., J Biomol Screen, 12, 13, 10.1177/1087057106296482 · DOI · Paper page
Cited by
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Self-citationThree-dimensional cell culture: the missing link in drug discovery
Breslin, S., & O’Driscoll, L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.003 · Cited by 1,332
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
“To tackle this, spheroids can be formed in a first step using ultra low attachment plates and can then be transferred to spinner flasks after selecting the right size of spheroids [27].”
Hickman, J. A., Graeser, R., de Hoogt, R., Vidic, S., Brito, C., Gutekunst, M., van der Kuip, H., & IMI PREDECT consortium (2014) · Biotechnology Journal · doi:10.1002/biot.201300492 · Cited by 380
Bispecific antibodies and their applications
Fan, G., Wang, Z., Hao, M., & Li, J. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0227-0 · Cited by 288
Metadata
- Authors
- Hirschhaeuser, F., Leidig, T., Rodday, B., Lindemann, C., & Mueller-Klieser, W.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 14
- Issue
- 8
- Pages
- 980-990
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W2145266027
- Cited by
- 46
- References
- 12
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4616 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Test System for Trifunctional Antibodies in 3D MCTS Culture. https://app.cochat.ai/papers/10.1177/1087057109341766
- The paper
- Hirschhaeuser, F., Leidig, T., Rodday, B., Lindemann, C., & Mueller-Klieser, W. (2009). Test System for Trifunctional Antibodies in 3D MCTS Culture. SLAS Discovery. https://doi.org/10.1177/1087057109341766
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.